Covered recipient · General Payments record
BUFFI G BOYD
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$6,262.66
- Reported across 175 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $567.82 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $222.50 | 16 |
| Medtronic, Inc. | $97.47 | 5 |
| Sumitomo Pharma America, Inc. | $72.23 | 4 |
| Merck Sharp & Dohme Corporation | $49.49 | 2 |
| Endo Pharmaceuticals Inc. | $37.82 | 2 |
| DAVOL INC. | $31.41 | 1 |
| PFIZER INC. | $23.94 | 1 |
| Astellas Pharma US Inc | $19.77 | 1 |
| Innovation Technologies Inc | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.13 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357944 | CMS |
| ABBVIE INC. | $21.51 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357946 | CMS |
| ABBVIE INC. | $4.95 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357948 | CMS |
| ABBVIE INC. | $15.21 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357950 | CMS |
| ABBVIE INC. | $13.03 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357952 | CMS |
| ABBVIE INC. | $18.56 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357954 | CMS |
| ABBVIE INC. | $3.04 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357956 | CMS |
| ABBVIE INC. | $3.27 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357958 | CMS |
| ABBVIE INC. | $2.83 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357960 | CMS |
| ABBVIE INC. | $18.33 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357962 | CMS |
| ABBVIE INC. | $21.24 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357964 | CMS |
| ABBVIE INC. | $9.38 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357966 | CMS |
| ABBVIE INC. | $21.61 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357968 | CMS |
| ABBVIE INC. | $20.31 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357970 | CMS |
| ABBVIE INC. | $19.41 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357972 | CMS |
| ABBVIE INC. | $20.69 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103357974 | CMS |
| Astellas Pharma US Inc | $19.77 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323314 | CMS |
| Davol Inc. | $31.41 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127664433 | CMS |
| Endo Pharmaceuticals Inc. | $23.14 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137012834 | CMS |
| Endo Pharmaceuticals Inc. | $14.68 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137012836 | CMS |
| Innovation Technologies Inc | $13.19 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130819427 | CMS |
| Medtronic, Inc. | $21.96 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119541983 | CMS |
| Medtronic, Inc. | $25.22 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119541985 | CMS |
| Medtronic, Inc. | $19.42 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119541989 | CMS |
| Medtronic, Inc. | $16.15 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119541987 | CMS |
| Medtronic, Inc. | $14.72 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119541991 | CMS |
| Merck Sharp & Dohme LLC | $26.48 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141796549 | CMS |
| Merck Sharp & Dohme LLC | $23.01 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141796381 | CMS |
| PFIZER INC. | $23.94 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131700441 | CMS |
| Sumitomo Pharma America, Inc. | $18.26 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830565 | CMS |
| Sumitomo Pharma America, Inc. | $21.75 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830567 | CMS |
| Sumitomo Pharma America, Inc. | $17.72 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830569 | CMS |
| Sumitomo Pharma America, Inc. | $14.50 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830571 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.